AAAAAA

   
Results: 1-12 |
Results: 12

Authors: WIERNIK PH DUTCHER JP EINZIG AI SPARANO J FRANK M FRIEDENBERG W
Citation: Ph. Wiernik et al., MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE, The cancer journal from Scientific American, 4(4), 1998, pp. 254-260

Authors: EINZIG AI WIERNIK PH WADLER S KAPLAN J BENSON LT TENTORAMANO L TAN V
Citation: Ai. Einzig et al., PHASE-I STUDY OF PACLITAXEL (TAXOL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH UNRESECTABLE MALIGNANCY, Investigational new drugs, 16(1), 1998, pp. 29-36

Authors: SKLARIN NT LATHIA CD BENSON L GROVE WR THOMAS S ROCA J EINZIG AI WIERNIK PH
Citation: Nt. Sklarin et al., A PHASE-I TRIAL AND PHARMACOKINETIC EVALUATION OF CI-980 IN PATIENTS WITH ADVANCED SOLID TUMORS, Investigational new drugs, 15(3), 1997, pp. 235-246

Authors: FRISHMAN WH YEE HCM KEEFE D DUTCHER J SUNG HM LIU LL EINZIG AI
Citation: Wh. Frishman et al., CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY, Current problems in cancer, 21(6), 1997, pp. 308-360

Authors: EINZIG AI NEUBERG D REMICK SC KARP DD ODWYER PJ STEWART JA BENSON AB
Citation: Ai. Einzig et al., PHASE-II TRIAL OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT PREVIOUSLY UNTREATED WITH CYTOTOXIC CHEMOTHERAPY - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) RESULTS OF PROTOCOL E1293, Medical oncology, 13(2), 1996, pp. 87-93

Authors: EINZIG AI SCHUCHTER LM RECIO A COATSWORTH S RODRIQUEZ R WIERNIK PH
Citation: Ai. Einzig et al., PHASE-II TRIAL OF DOCETAXEL (TAXOTERE) IN PATIENTS WITH METASTATIC MELANOMA PREVIOUSLY UNTREATED WITH CYTOTOXIC CHEMOTHERAPY, Medical oncology, 13(2), 1996, pp. 111-117

Authors: FRISHMAN WH SUNG HM YEE HCM LIU LL EINZIG AI DUTCHER J KEEFE D
Citation: Wh. Frishman et al., CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY - INTRODUCTION, Current problems in cardiology, 21(4), 1996, pp. 233

Authors: EINZIG AI DUTCHER JP WIERNIK PH
Citation: Ai. Einzig et al., LIFE-THREATENING HYPERLEUKOCYTOSIS AND PULMONARY COMPROMISE AFTER PRIMING WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN A PATIENT WITH ACUTE MYELOMONOCYTIC LEUKEMIA, Journal of clinical oncology, 13(1), 1995, pp. 304-305

Authors: EINZIG AI LIPSITZ S WIERNIK PH BENSON AB
Citation: Ai. Einzig et al., PHASE-II TRIAL OF TAXOL IN PATIENTS WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL-TRACT (UGIT) - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP(ECOG) RESULTS, Investigational new drugs, 13(3), 1995, pp. 223-227

Authors: EINZIG AI
Citation: Ai. Einzig, PACLITAXEL (TAXOL(R)) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER - REVIEW OF PHASE-II TRIALS, International journal of gynecological cancer, 4, 1994, pp. 3-6

Authors: KAPLAN JG EINZIG AI SCHAUMBURG HH
Citation: Jg. Kaplan et al., TAXOL CAUSES PERMANENT LARGE FIBER PERIPHERAL-NERVE DYSFUNCTION - A LESSON FOR PREVENTATIVE STRATEGIES, Journal of neuro-oncology, 16(2), 1993, pp. 105-107

Authors: DUTCHER JP WIERNIK PH EINZIG AI CASSILETH P
Citation: Jp. Dutcher et al., MITOXANTRONE, VINBLASTINE AND CCNU (MVC) - A HIGHLY-ACTIVE REGIMEN INPOOR-PROGNOSIS HODGKINS-DISEASE (HD), Blood, 82(10), 1993, pp. 10000143-10000143
Risultati: 1-12 |